Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Study protocol

An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]

Stephen Clarke*, Matt Burge, Cassandra Cordwell, Peter Gibbs, William Reece and Niall Tebbutt

BMC Cancer 2013, 13:120  doi:10.1186/1471-2407-13-120

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 70 accesses
  • Last 365 days: 595 accesses
  • All time: 1891 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information